inactivation p53 pathway retinoblastoma 
human tumours genetic mutations rb p53 pathways retinoblastoma thought exception studies suggest retinoblastomas initiate mutations gene retinoblastoma rb1 bypass p53 pathway arise intrinsically death-resistant cells retinal development contrast prevailing theory show tumour surveillance pathway mediated arf mdm2 mdmx p53 activated loss rb1 retinogenesis rb1-deficient retinoblasts undergo p53-mediated apoptosis exit cell cycle subsequently amplification mdmx gene increased expression mdmx protein strongly selected tumour progression mechanism suppress p53 response rb1-deficient retinal cells data provide evidence p53 pathway inactivated retinoblastoma cancer originate intrinsically death-resistant cells previously thought addition support idea mdmx specific chemotherapeutic target treating retinoblastoma 
